Travoprost Intraocular Implant + iStent Infinite
ConditionGlaucoma, Open-Angle
Trial statusRecruiting
Trial phasePhase 4
Trial typeInterventional
Biological sexAll
Age18+
SponsorGlaukos Corporation
About this trial
Adult subjects with elevated intraocular pressure will be randomized to receive iStent infinite trabecular bypass system plus a travoprost intraocular implant or receive a sham procedure plus a travoprost intraocular implant and be followed for 12 months.
Eligibility criteria
Qualifiers
diagnosis of open-angle glaucoma or ocular hypertension
qualifying IOP in the study eye
Disqualifiers
unmedicated (washed out) IOP of >36 mmHg in the study eye
hypersensitivity to travoprost or any other components of the travoprost intraocular implant
vertical cup/disc ratio > 0.8 in the study eye
best spectacle corrected visual acuity of worse than 20/80 in either eye
Trial design
Treatments tested in this trial
- Travoprost Intraocular Implant
- iStent infinite
- Sham procedure
Treatment groups
150 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov